Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1)H R Lijnen, B Van Hoef, K Umans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injuryH R Lijnen, B Van Hoef, M Dewerchin, et al.
European Journal of Biochemistry|September 15, 1994
Characterization of the murine plasma fibrinolytic systemH R Lijnen, B van Hoef, V Beelen, et al.
Thrombosis and Haemostasis|August 2, 1993
Functional properties of p-anisoylated plasmin-staphylokinase complexH R Lijnen, B Van Hoef, R A Smith, et al.
Blood|May 15, 1989
The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitroH R Lijnen, B Van Hoef, F De Cock, et al.
Thrombosis and Haemostasis|August 13, 1990
Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PAH R Lijnen, B Van Hoef, F De Cock, et al.
European Journal of Biochemistry|November 15, 1988
Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160H R Lijnen, L Nelles, B Van Hoef, et al.
Biochemistry|January 13, 2000
Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium SpH R Lijnen, B Van Hoef, F Ugwu, et al.
Biochemical and Biophysical Research Communications|September 8, 2009
Stromelysin-2 (MMP-10) deficiency does not affect adipose tissue formation in a mouse model of nutritionally induced obesityH R Lijnen, B Van Hoef, J A Rodriguez, et al.
Blood|May 9, 2001
Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalizationN Nagai, M De Mol, B Van Hoef, et al.
Pageof 6